1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsResearch Collaboration (ARC) Grant Program (American Brain Tumor Association) is sponsored by American Brain Tumor Association (ABTA). This annual grant requires a collaborative project among multiple (at least 2) principal investigators focused on brain tumor research.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Research Collaboration Grants - American Brain Tumor Association Research Collaboration Grants Research Collaboration Grants The ABTA’s Research Program supports both established and new scientists in discovering more about the causes, effects, diagnosis, and treatment of brain tumors.
ABTA Research Collaboration Grants Research Collaboration Grants a re two-year, $200,000 grants for multi-investigator and multi-institutional brain tumor collaborative research projects. They are intended to promote team science, streamlining and accelerating research progress. Research projects must be conducted by a team of at least two co-principal investigators (Co-PI’s) from different institutions.
The research project should be multidisciplinary, incorporating multiple components such as basic, translational, clinical, and epidemiological research. The ABTA is accepting Letters of Intent through December 10, 2025.
Read the 2026 Request for Applications Your research can make a difference With their 2017 ABTA Research Collaboration Grant, Ben Ellingson, PhD and Elizabeth Gerstner, MD are using diffusion MRI to determine whether they can predict which recurrent glioblastoma patients can benefit from anti-angiogenic therapy.
Through a retrospective analysis of 5 individual multicenter clinical trials, they discovered a correlation between tumors with a high Apparent Diffusion Coefficient and longer survival among rGBM patients on anti-angiogenic monotherapy. Their findings have been published in Clinical Cancer Research.
This research team is moving forward with a prospective multicenter clinical trial to validate these findings, and a surgical study to better understand the mechanisms underlying this effect.
According to the current listing, eligibility includes: Multiple (at least 2) principal investigators collaborating on brain tumor research. Confirm the full requirements in the official notice before applying.
The current listing shows $200,000 (2 years). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Research Collaboration (ARC) Grant Program (American Brain Tumor Association) is funded by American Brain Tumor Association (ABTA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Special Project Grants (through the Flexible Research Fund) is sponsored by American Brain Tumor Association (ABTA). The ABTA Flexible Research Fund is a flexible approach to target research funding to key gaps in the brain tumor funding landscape. Special Project Grants supported by the fund are vetted by a committee of scientific and patient advocate reviewers.
American Brain Tumor Association Discovery Grant is sponsored by American Brain Tumor Association (ABTA). Discovery Grants are one-year awards for high-risk, high-impact research with the potential to change current diagnostic or treatment models for brain tumors. They are intended to provide seed-funding for early-stage faculty-level researchers to develop new ideas and gather preliminary data for larger grants.
ARPA-H's HEARING program (ARPA-H-SOL-26-154) — Hearing Enhancement through ARtificially Intelligent NeurotechnoloGy — held its Proposers' Day on June 8, 2026 and set Solution Summary deadlines for June 29 with Full Proposals due August 14. Single prime awardee, multiple Other Transaction Agreements, three integrated technical areas spanning intracortical recording and stimulation devices, wearable dynamic sound modulators, and AI-based auditory read/write algorithms. The first phase runs 18 months; the full effort runs 4.5 years through first-in-human clinical studies. For neurotech teams that have spent a decade in cochlear-implant or visual-prosthesis space, this is the moment the federal government bet on auditory cortex over the cochlea.
Read articleA Nature poll finds three-quarters of American scientists are considering working abroad. ERC applications from U.S. researchers have tripled. France and the EU pledged €500 million to recruit them. Inside the brain drain reshaping global science — and what it means for grant strategy.
Read article